1Ober C,Aldrich C L.HLA-G polymorphisms:neutral evolution or novel function[J].Reprod Immunol,1997; 36:1-21.
2Le Bouteiller P.HLA-G in the human placenta:expression and potential functions[J].Biochem Soc Trans,2000; 28 (2):208-212.
3Morales P J,Pace J L,Platt J S et al.Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype[J].Immunol,2003 ;171:6215-6224.
4McIntire R H,Morales P J,Petroff M G et al.Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-β[J].Leukoc Biol,2004 ;76:1220-1228.
5Shiroishi M,Tsumoto K,Amano K et al.Human inhibitory receptors Ig-like transcript 2 (ILT-2) and ILT-4 compete with CD8 for MHC class Ⅰ binding and bind preferentially to HLA-G[J].Proc Natl Acad Sci,2003; 100 (15):8856-8861.
7Contini P,Ghio M,Poggi A et al.Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8-cells and inhibit cytotoxic T cell activity through CD8 ligation[J].Immunol,2002 ;33 (1):125-134.
8Le Rord S,Azema C,Krawice-Radanne et al.Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells[J].Immunol,2006; 176 (5):3266-3276.
9Bahri R,Hirsch F,Josse A et al.Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes[J].Immunol,2006;176(3):1331-1339.
10Soderstrom K,Corliss B,Lanier L L et al.CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells[J].Immunol,1997; 159(3):1072-1075.
